| Wang, Jing |
NCT04767828: A Single Arm Study of Brain Metastasis in Patients With HER2-positive Breast Cancer |
|
|
| Recruiting | 4 | 43 | RoW | PYRROTINI, CAPECITABINE, Brain radiation therapy | Tianjin Medical University Cancer Institute and Hospital | TTP | 06/22 | 06/22 | | |
NCT06561711: Optimization of Minocycline for Helicobacter Pylori Rescue Treatment |
|
|
| Recruiting | 4 | 476 | RoW | Vonoprazan, Bismuth Potassium Citrate, Tetracycline,Metronidazole, Minocycline,Metronidazole | Shanghai Jiao Tong University School of Medicine | Helicobacter Pylori Infection | 08/26 | 08/26 | | |
NCT05874544: Rescue Therapy for Helicobacter Pylori Infection |
|
|
| Recruiting | 4 | 360 | RoW | Vonoprazan, Bismuth Potassium Citrate, Tetracycline, Metronidazole, Amoxicillin, Rifabutin | Shanghai Jiao Tong University School of Medicine | Helicobacter Pylori Infection | 12/24 | 12/24 | | |
NCT04337632: Evaluation of the Sensitivity to Different Chemotherapy Regimens in Platinum-Partial Sensitive Recurrent Ovarian Cancer |
|
|
| Recruiting | 3 | 338 | RoW | Doxorubicin Hydrochloride Liposome Injection+carboplatin, PP, paclitaxel +carboplatin, TP | Hunan Cancer Hospital | Ovarian Cancer | 06/21 | 06/21 | | |
NCT05622890: A Single-arm Clinical Trial of IMGN853 in Chinese Adult Patients With Platinum-resistant, Epithelial Ovarian Cancer |
|
|
| Recruiting | 3 | 35 | RoW | Mirvetuximab Soravtansine, IMGN853, MIRV | Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd. | Epithelial Ovarian Cancer, Peritoneal Cancer, Fallopian Tube Cancer | 04/23 | 12/23 | | |
NCT05745259: Thrombolysis Treated With TNK-tPA in Acute Ischemic Stroke Patients （3T Stroke-Ⅲ） |
|
|
| Recruiting | 3 | 1630 | RoW | Alteplase, rt-PA, Tenecteplase, TNK-tPA | Beijing Tiantan Hospital, Jiangsu FENG HUA Biotech Pharmaceutical Co., Ltd, The Place Pharmaceutical(Jiangsu) Co., Ltd | Acute Ischemic Stroke | 11/23 | 03/24 | | |
NCT05525637: Safety and Efficacy Study of YZJ-1139 in Insomnia Disorder |
|
|
| Recruiting | 3 | 1041 | RoW | YZJ-1139 20mg, YZJ-1139 40mg, Placebo | Shanghai Haiyan Pharmaceutical Technology Co., Ltd. | Insomnia Disorder | 12/24 | 12/24 | | |
NCT05042375: A Trial of Camrelizumab Combined With Famitinib Malate in Treatment Naïve Subjects With PD-L1-Positive Recurrent or Metastatic Non-Small Cell Lung Cancer |
|
|
| Recruiting | 3 | 450 | RoW | camrelizumab + famitinib, pembrolizumab, camrelizumab | Jiangsu HengRui Medicine Co., Ltd. | Non-small Cell Lung Cancer | 12/23 | 12/25 | | |
NCT05115942: Hydronidone for the Treatment of Liver Fibrosis Associated with Chronic Viral Hepatitis B Phase 3 Trial. |
|
|
| Completed | 3 | 248 | RoW | Hydronidone capsules, F351, The placebo capsules, N | Beijing Continent Pharmaceutical Co, Ltd. | Liver Fibrosis | 10/24 | 10/24 | | |
| Recruiting | 3 | 750 | US | Continuous ketamine infusion, Ketamine + Saline, Placebo | NYU Langone Health, National Cancer Institute (NCI) | Chronic Postsurgical Pain | 10/24 | 10/25 | | |
NCT06584032: Study of Fruquintinib Plus Sintilimab for Treatment of Advanced Endometrial Cancer |
|
|
| Recruiting | 3 | 412 | RoW | fruquintinib, HMPL-013, sintilimab, IBI308, paclitaxel, doxorubicin | Hutchmed | Advanced Endometrial Cancer | 01/29 | 06/29 | | |
NCT06717152: Efficacy and Safety of SJP-0132 Eye Drops in Chinese Patients With Dry Eye Disease |
|
|
| Recruiting | 3 | 400 | RoW | SJP-0132, Placebo | Senju Pharmaceutical Science & Technology (Beijing) Co., Ltd., Senju Pharmaceutical Co., Ltd. | Dry Eye | 07/25 | 08/25 | | |
NCT05180734: PD1 Combined With Chemotherapy for Adjuvant Treatment of Gastric Cancer |
|
|
| Active, not recruiting | 3 | 878 | RoW | JS001/Placebo, Postoperative Adjuvant Chemotherapy, JS001/placebo combine with Postoperative Adjuvant Chemotherapy | Shanghai Junshi Bioscience Co., Ltd. | Gastric or Esophagogastric Junction Adenocarcinoma | 06/26 | 07/28 | | |
| Active, not recruiting | 3 | 90 | Europe, Canada, US, RoW | Pimicotinib(ABSK021), Placebo | Abbisko Therapeutics Co, Ltd | Tenosynovial Giant Cell Tumor, Pigmented Villonodular Synovitis, Giant Cell Tumor of Tendon Sheath | 05/26 | 06/28 | | |
NCT06095583: Phase 3 Study of Toripalimab Alone or in Combination With Tifcemalimab as Consolidation Therapy in Patients With Limited-stage Small Cell Lung Cancer (LS-SCLC) |
|
|
| Recruiting | 3 | 756 | Europe, US, RoW | Tifcemalimab injection, toripalimab injection, Placebo for Tifcemalimab, Placebo for toripalimab | Shanghai Junshi Bioscience Co., Ltd. | Limited-stage Small Cell Lung Cancer (LS-SCLC) | 07/27 | 07/29 | | |
NCT05905172: Hydronidone Capsules in Long-term Treatment in Patients With Chronic Viral Hepatitis B Liver Fibrosis |
|
|
| Recruiting | 3 | 248 | RoW | Hydronidone capsules, F351, The placebo capsules, N | Beijing Continent Pharmaceutical Co, Ltd. | Liver Fibrosis | 06/28 | 10/28 | | |
ORIENT, NCT05401071: Optimizing(O) RIfapentine-based(RI) Regimen and shortENing(EN) the Treatment of Drug-sensitive Tuberculosis(T) |
|
|
| Recruiting | 2/3 | 2442 | RoW | Short Regimen with Rifapentine 10mg/kg, Standardized Regimen, Short Regimen with Rifapentine 15mg/kg, Short Regimen with Rifapentine 20mg/kg | Huashan Hospital | Tuberculosis, Pulmonary | 10/24 | 11/27 | | |
TQB2450-II-08, NCT04574284: A Study of TQB2450 Injection Combined With Anlotinib Hydrochloride Capsule in Subjects With Advanced Endometrial Cancer |
|
|
| Recruiting | 2 | 196 | RoW | TQB2450, Anlotinib | Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | Advanced Endometrial Cancer | 12/21 | 04/22 | | |
COMPASSION-13, NCT04868708: A Study of AK104（ an Anti-PD-1 and Anti-CTLA-4 Bispecific Antibody) in Recurrent or Metastatic Cervical Cancer |
|
|
| Completed | 2 | 50 | RoW | AK104, Bevacizumab, Paclitaxel, PTX, Cisplatin or Carboplatin, DDP,CBP | Akeso | Recurrent or Metastatic Cervical Cancer | 02/24 | 02/24 | | |
TQB2450-ALTN-II-02, NCT06141226: Phase II Clinical Trial to Evaluate the Safety and Efficacy of TQB2450 Injection Combined With Anlotinib Capsule and Chemotherapy in the Treatment of Immunoresistant Advanced Non-small Cell Lung Cancer |
|
|
| Recruiting | 2 | 148 | RoW | TQB2450 +Anlotinib+Docetaxel, TQB2450/Anlotinib/Docetaxel, TQB2450 +Androtinib Placebo+Docetaxel, TQB2450/Anlotinib Placebo/Docetaxel | Tianjin Medical University Cancer Institute and Hospital | Non-small-cell Lung Cancer | 12/27 | 12/28 | | |
TQB2858-II-01, NCT05121363: A Clinical Trial to Evaluate TQB2858 Injection Combined With Anlotinib Hydrochloride Capsule in the Treatment of Recurrent or Metastatic Advanced Endometrial Carcinoma |
|
|
| Not yet recruiting | 2 | 113 | RoW | TQB2858 injection, Anlotinib Hydrochloride capsules | Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | Endometrial Carcinoma | 05/23 | 07/23 | | |
| Completed | 2 | 150 | US, RoW | Paclitaxel, Afuresertib, LAE002 | Laekna Limited | Platinum-resistant Ovarian Cancer | 07/23 | 06/24 | | |
NCT06173037: RC88 in Platinum-Resistant Recurrent Epithelial Ovarian Cancer, Fallopian Tube Cancer, and Primary Peritoneal Cancer |
|
|
| Recruiting | 2 | 88 | RoW | RC88, RC88 for Injection | RemeGen Co., Ltd. | Primary Peritoneal Cancer, Fallopian Tube Cancer, Epithelial Ovarian Cancer | 06/26 | 12/26 | | |
NCT05269173: Efficacy and Safety of Flos Gossypii Flavonoids Tablet in the Treatment of Alzheimer's Disease |
|
|
| Completed | 2 | 240 | RoW | Flos gossypii flavonoids tablet | Capital Medical University, Xinjiang Uygur Pharmaceutical Co., Ltd. | Alzheimer Disease | 08/24 | 11/24 | | |
NCT06632262: A Phase 2 Clinical Study of ABSK061 and ABSK043 |
|
|
| Not yet recruiting | 2 | 202 | RoW | ABSK061 + ABSK043, ABSK061+ABSK043 in combination with CAPOX | Abbisko Therapeutics Co, Ltd | HER2-Gastric/Gastroesophageal Junction Cancer, Urothelial Carcinoma, Non-Small Cell Lung Cancer, Solid Tumors | 11/29 | 06/30 | | |
NCT05033132: A Phase II Study of Balstilimab Independently or in Combination With Zalifrelimab in Advanced Cervical Cancer |
|
|
| Withdrawn | 2 | 177 | RoW | Balstilimab, Balstilimab + Zalifrelimab | Agenus Inc., Betta Pharmaceuticals Co., Ltd. | Cervical Cancer | 12/24 | 12/24 | | |
NCT06223308: A Study Evaluating the Safety and Efficacy of HB0028 in Subjects With Advanced Solid Tumors |
|
|
| Recruiting | 1/2 | 54 | RoW | HB0028, Anti-PD-L1 and TGF-β bifunctional fusion protein | Shanghai Huaota Biopharmaceutical Co., Ltd. | Advanced Solid Tumor, Cervical Cancer | 05/24 | 10/24 | | |
| Recruiting | 1/2 | 310 | RoW | ICP-723 | Beijing InnoCare Pharma Tech Co., Ltd. | Solid Tumors | 06/25 | 02/28 | | |
NCT06308406: A Phase Ib/II Clinical Study of HRS-1167 in Combination With Bevacizumab in Patients With Recurrent Ovarian Cancer |
|
|
| Recruiting | 1/2 | 54 | RoW | Bevacizumab； HRS-1167 | Jiangsu HengRui Medicine Co., Ltd. | Recurrent Ovarian Cancer | 10/25 | 10/25 | | |
NCT05551507: IN10018 in Combination With Standard Chemotherapy in High-grade Serous Epithelial Ovarian Cancer |
|
|
| Recruiting | 1/2 | 150 | RoW | IN10018 in combination with PLD, IN10018 add on to PLD treatment | InxMed (Shanghai) Co., Ltd. | Platinum-resistant Ovarian Cancer | 06/24 | 12/24 | | |
| Active, not recruiting | 1/2 | 50 | RoW | Cadonilimab, AK104, Anlotinib, AL3818, Docetaxel, Docetaxel Trihydrate, Docetaxel Hydrate, Taxoltere Metro, RP 56976, RP-56976, RP56976, Docetaxel Anhydrous, N-Debenzoyl-N-tert-butoxycarbonyl-10-deacetyltaxol, N Debenzoyl N tert butoxycarbonyl 10 deacetyltaxol, NSC 628503, Taxotere | Shanghai Chest Hospital, The Affiliated Hospital of Qingdao University, Anhui Provincial Hospital, Zhejiang University | NSCLC Stage IV, NSCLC Stage IIIB, NSCLC Stage IIIC | 12/24 | 12/25 | | |
| Recruiting | 1/2 | 404 | US, RoW | Rina-S, PRO1184, Rinatabart sesutecan, GEN1184, Carboplatin, Bevacizumab, Pembrolizumab | Genmab | Platinum-Resistant Ovarian Cancer, Platinum Sensitive Ovarian Cancer (PSOC), High Grade Epithelial Ovarian Cancer, High Grade Serous Ovarian Cancer, Primary Peritoneal Carcinoma, Fallopian Tube Cancer, Endometrial Cancer, Non-small Cell Lung Cancer, Epidermal Growth Factor Receptor (EGFR)-Mutated Non-Small Cell Lung Cancer (NSCLC), Mesothelioma, Breast Adenocarcinoma, Triple Negative Breast Cancer, Hormone Receptor-positive/Her2 Negative Breast Cancer | 04/26 | 10/26 | | |
NCT05901987: Evaluation of Safety and Efficacy of Gene Therapy Drug in the Treatment of Spinal Muscular Atrophy (SMA) Type 2 Patients |
|
|
| Recruiting | 1/2 | 33 | RoW | GC101 | GeneCradle Inc | SMA II | 05/25 | 12/28 | | |
NCT06058091: RY_SW01 Cell Injection Therapy in Systemic Sclerosis |
|
|
| Recruiting | 1/2 | 81 | RoW | RY_SW01 cell injection, UC-MSC treatment, Basic treatment, immunosuppressor | Jiangsu Renocell Biotech Company, The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School | Systemic Sclerosis | 12/25 | 12/35 | | |
FZPL-Ⅰ-120, NCT04718740: A Drug-drug Interaction Study Of Fluzoparib (SHR3162) on Patients With Recurrent Ovarian Cancer |
|
|
| Completed | 1 | 33 | RoW | fluzoparib, caffeine, vitamin K, warfarin, omeprazole, midazolam, repaglinide and bupropion | Jiangsu HengRui Medicine Co., Ltd. | Recurrent Ovarian Cancer | 10/22 | 07/23 | | |
NCT06232863: A Study of BH009 in Head and Neck Squamous Cell Carcinoma and Ovarian Cancer |
|
|
| Recruiting | 1 | 24 | RoW | BH009 | Zhuhai Beihai Biotech Co., Ltd | Solid Tumor, Adult | 03/24 | 04/24 | | |
TQB2858-Ⅰ-06, NCT05068921: A Clinical Trial to Evaluate Tolerability and Pharmacokinetics of TQB2858 Injection in Subjects With Advanced Malignancy |
|
|
| Recruiting | 1 | 40 | RoW | TQB2858 injection | Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | Advanced Cervical Cancer | 05/23 | 07/23 | | |
NCT05539768: Study on the Safety and Efficacy of Autogenous Tumor Infiltrates Lymphocytes for the Treatment of Advanced Solid Tumor |
|
|
| Not yet recruiting | 1 | 8 | NA | HS-IT101 | The Affiliated Hospital of Qingdao University, Qingdao Sino-Cell Biomedicine Co.,Ltd. | Advanced Solid Tumor | 12/23 | 03/27 | | |
NCT05498597: AMT-151 in Patients With Selected Advanced Solid Tumours |
|
|
| Recruiting | 1 | 30 | RoW | AMT-151 | Multitude Therapeutics Inc., Tigermed Consulting Co., Ltd | Advanced Solid Tumor, Advanced Cancer, Advanced Carcinoma, Ovarian Cancer, Ovarian Carcinoma, Ovarian Epithelial Cancer, Ovarian Endometrioid Adenocarcinoma, Endometrial Cancer, Endometrial Adenocarcinoma, Endometrial Serous Adenocarcinoma, Endometrial Endometrioid Adenocarcinoma, Endometrial Clear Cell Adenocarcinoma, Lung Adenocarcinoma, Triple Negative Breast Cancer, Pancreatic Ductal Adenocarcinoma, Malignant Pleural Mesothelioma, Ovarian Clear Cell Carcinoma, Ovarian Clear Cell Adenocarcinoma, Ovarian Mucinous Adenocarcinoma | 01/24 | 10/24 | | |
NCT05673538: TT-00973-MS Tablets in Patients With Advanced Solid Tumors |
|
|
| Not yet recruiting | 1 | 40 | RoW | TT-00973-MS tablets treatment | TransThera Sciences (Nanjing), Inc. | Advanced Solid Tumor | 12/24 | 12/25 | | |
NCT05473624: Study of HRS-1167 as Monotherapy in Patients With Advanced Solid Tumors |
|
|
| Recruiting | 1 | 153 | RoW | HRS-1167 | Jiangsu HengRui Medicine Co., Ltd. | Advanced Solid Tumors | 12/24 | 12/24 | | |
NCT05781360: A Study to Investigate the Safety, Tolerability, Pharmacokinetics and Preliminary Antitumor Activity of SIM0237 in Adult Participants with Advanced Solid Tumors |
|
|
| Terminated | 1 | 192 | US, RoW | SIM0237 | Jiangsu Simcere Pharmaceutical Co., Ltd., Shanghai Xianxiang Medical Technology Co., Ltd., Simcere Zaiming | Locally Advanced Unresectable or Metastatic Solid Tumor | 05/24 | 05/24 | | |
| Recruiting | 1 | 144 | US, RoW | ADRX-0706 | Adcentrx Therapeutics | Solid Tumors, Triple Negative Breast Cancer (TNBC), Urothelial Cancer, Cervical Cancer | 09/25 | 12/26 | | |
NCT05897775: Coordinated Reset Deep Brain Stimulation for Essential Tremor |
|
|
| Recruiting | 1 | 23 | US | Deep brain stimulation | University of Minnesota | Essential Tremor, Upper Extremity Essential Tremor | 12/27 | 06/28 | | |
Pan-CHESS1801, NCT03778775: Transient Elastography (FibroTouch) for Assessing Risk of Gastroesophageal Varices Bleeding in Compensated Cirrhosis |
|
|
| Recruiting | N/A | 200 | Japan, RoW | Liver sitffness measurement, Esophagogastroduodenoscopy | Nanfang Hospital of Southern Medical University, Beijing Tsinghua Changgeng Hospital, LanZhou University, Beijing 302 Hospital, Xijing Hospital of Digestive Diseases, Wuhan Union Hospital, China, Zhujiang Hospital, Second Affiliated Hospital of Xi'an Jiaotong University, The Central Hospital of Lishui City, Xingtai People's Hospital, Seventh Medical Center of PLA Army General Hospital, Shandong Provincial Hospital, Shunde Hospital, Southern Medical University, Medistra Hospital, University of Indonesia, Ankara University, Osaka City University, Chulalongkorn University | Compensated Liver Cirrhosis, Gastroesophageal Varices Bleeding | 06/21 | 03/22 | | |
NCT06170528: ARUA-ALZ - Connecting Audio and Radio SensingmSystems to Improve Care at Home for ADRD |
|
|
| Completed | N/A | 9 | US | AURA_ALZ | Florida State University, University of North Carolina, Chapel Hill, The University of Texas Health Science Center at San Antonio | Alzheimer Disease, Caregiver Burden | 07/24 | 07/24 | | |
NCT06267365: Predictive Biomarker for Endoscopic Therapy in Chronic Pancreatitis |
|
|
| Recruiting | N/A | 100 | US | | NYU Langone Health, National Institute of Neurological Disorders and Stroke (NINDS) | Chronic Pancreatitis | 06/25 | 09/25 | | |
NCT05875402: XKDCT080 in GCC-positive Recurrent or Refractory Solid Tumors With Single Center, Single Arm, and Dose Escalation |
|
|
| Recruiting | N/A | 9 | RoW | Chimeric antigen receptor T cell preparation targeting GCC | The Affiliated Hospital of Qingdao University | Colon Cancer | 12/23 | 05/25 | | |
| Completed | N/A | 49 | US | | Florida State University, Diabetes Technology Society | Diabetes Mellitus, Diabetes Mellitus, Type 2, Diabetes Mellitus, Type 1 | 04/24 | 04/24 | | |
NCT06422052: Epidemiological Investigation of Helicobacter Pylori-infected Patients and the Effect of Eradication Treatment on Dyspepsia Symptoms |
|
|
| Recruiting | N/A | 2242 | RoW | Epidemiological questionnaire and Functional Dyspepsia Symptom Diary（FDSD） | Shanghai Jiao Tong University School of Medicine | Helicobacter Pylori Infection, Dyspepsia | 05/25 | 05/25 | | |
NCT06448455: Observation on the Frailty Status of Lung Cancer Patients |
|
|
| Recruiting | N/A | 200 | RoW | Observation | Peking University Third Hospital | Lung Cancer | 07/24 | 12/24 | | |
NCT06769893: A Study Evaluating the Value of 68Ga-NOTA-RCCB6 PET Imaging for Targeting CD70 in the Clinical Staging, Therapeutic Evaluation, and Restaging of Renal Cell Carcinoma, and Comparing It with 68Ga-PSMA PET/CT Imaging |
|
|
| Recruiting | N/A | 60 | RoW | 68Ga-NOTA-RCCB6 PET/CT Scan | Xijing Hospital | RCC, Renal Cell Cancer | 04/25 | 11/25 | | |
| Recruiting | N/A | 10000 | RoW | Installation or registration of smartphone application | Chinese Alliance Against Lung Cancer | Solitary Pulmonary Nodule | 10/25 | 10/25 | | |
INSPIRE-TB, NCT05081401: Innovating(IN) Shorter(S), All- Oral, Precised(P), Individualized(I) Treatment Regimen(RE) for Rifampicin Resistant Tuberculosis |
|
|
| Recruiting | N/A | 3000 | RoW | This is a non-intervention observational study. | Huashan Hospital | Multidrug Resistant Tuberculosis | 12/25 | 12/25 | | |
NCT03563976: Multiparametric Image Analysis and Correlation With Outcomes in Lung Cancer Screening and Early Stage Lung Cancer |
|
|
| Active, not recruiting | N/A | 885 | US | Retrospective Study | University of Texas Southwestern Medical Center | Lung Cancer | 03/26 | 03/28 | | |
BIRKIN, NCT05603078: A Prospective Study of Preoperative Tumor-bed Boost Followed by Oncoplastic Surgery and Adjuvant Whole Breast Radiotherapy for Early Stage Breast Cancer |
|
|
| Recruiting | N/A | 102 | RoW | Preoperative MRI-guided tumor-bed boost and postopreative ultra-hypofractionated radiotherapy (26 Gy/5.2Gy/5) | Cancer Institute and Hospital, Chinese Academy of Medical Sciences | Breast Neoplasms | 07/26 | 07/28 | | |
| Recruiting | N/A | 900 | RoW | | Yantai Yuhuangding Hospital | Sepsis | 12/24 | 12/25 | | |
| Recruiting | N/A | 400 | RoW | | China-Japan Friendship Hospital, Chinese Academy of Medical Sciences, Second Affiliated Hospital, School of Medicine, Zhejiang University, Capital Medical University, Peking University Third Hospital, Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University | Obstructive Pulmonary Disease | 01/25 | 12/25 | | |
| Sun, Dan |
| Completed | 3 | 270 | Europe, Canada, Japan, US, RoW | Placebo, Soticlestat, TAK-935 | Takeda | Lennox Gastaut Syndrome (LGS) | 01/24 | 01/24 | | |
| Completed | 3 | 144 | Europe, Canada, Japan, US, RoW | Soticlestat, TAK-935, Placebo | Takeda | Dravet Syndrome (DS) | 04/24 | 04/24 | | |
| Recruiting | 3 | 400 | Europe, Canada, Japan, US, RoW | Soticlestat, TAK-935 | Takeda | Dravet Syndrome (DS), Lennox Gastaut Syndrome (LGS) | 05/26 | 05/26 | | |
| Recruiting | 3 | 2100 | Europe, Canada, Japan, US, RoW | Rimegepant/BHV3000, Matching placebo | Pfizer | Pediatric Migraine | 01/29 | 01/29 | | |
NCT05901987: Evaluation of Safety and Efficacy of Gene Therapy Drug in the Treatment of Spinal Muscular Atrophy (SMA) Type 2 Patients |
|
|
| Recruiting | 1/2 | 33 | RoW | GC101 | GeneCradle Inc | SMA II | 05/25 | 12/28 | | |
| Chen, Zhuo |
NCT05901987: Evaluation of Safety and Efficacy of Gene Therapy Drug in the Treatment of Spinal Muscular Atrophy (SMA) Type 2 Patients |
|
|
| Recruiting | 1/2 | 33 | RoW | GC101 | GeneCradle Inc | SMA II | 05/25 | 12/28 | | |
| Recruiting | N/A | 120 | US | Daoist Zhanzhuang, Sham Wall Squat | University of North Carolina, Charlotte | Stress, Physiological, Stress, Psychological, Inflammatory Response, Well-Being, Psychological | 02/27 | 07/27 | | |
